Search Results 571-580 of 17685 for SC
... SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma. Participation eligibility. Participant eligibility ...
The purpose of this randomized, double-blind study is to investigate the efficacy and safety of mepolizumab (300 milligram [mg] administered subcutaneously [SC] ...
... SC. Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone ... SC, Caggana M, Bryant SC, Caldwell SG, Camilot M, Campbell C, Carducci C ...
Bagheri SC, ed. Mandibular orthognathic surgery. In: Clinical Review of Oral and Maxillofacial Surgery. 3rd ed. Elsevier; 2025. https://www.clinicalkey.com ...
Adalimumab-adaz injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...
... (SC) blinatumomab in adult participants with active and refractory (SLE) with nephritis (Subprotocol B) and in adult participants with active refractory ...
The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...
The purpose of this study is to evaluate the safety and effectiveness of repeated subcutaneous (SC) administrations of Lanadelumab in preventing angioedema ...
... SC, Park SS, Deufel CL, Kavanaugh JA, Grams MP. Highs and Lows of Spatially Fractionated Radiation Therapy: Dosimetry and Clinical Outcomes. Pract Radiat ...
SC: Mayo Clinic Breadcrumb. Home · Blood Donor Program. Sections Blood Donor Program. Frequently asked questions · Platelet, double red blood cell and plasma ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.